Arizona Tribune - BioLargo Year-End 2024 Earnings Results Webcast and Conference Call on Monday, March 31, 2025

Arizona Tribune - BioLargo Year-End 2024 Earnings Results Webcast and Conference Call on Monday, March 31, 2025 - 4:00 PM Eastern Time

BioLargo Year-End 2024 Earnings Results Webcast and Conference Call on Monday, March 31, 2025 - 4:00 PM Eastern Time

WESTMINSTER, CALIFORNIA / ACCESS Newswire / March 28, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Monday, March 31, 2025 at 1:00 pm Pacific / 4:00 pm Eastern. Open to the public, the webcast will be held to review the company's financial results for the year ended December 31, 2024, discuss recent milestones, and conduct a question-and-answer session.

Text size:

To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.

To participate in the live webcast and teleconference:

Webcast Link: https://www.webcaster4.com/Webcast/Page/2448/52269
Teleconference Domestic: 888-506-0062
Teleconference International: +1-973-528-0011
Participant Access Code: 194389

To watch or listen to a replay of the webcast or teleconference:

Webcast Replay Expiration: Tuesday, July 01, 2025
Teleconference Replay Expiration: Monday, April 14, 2025
Teleconference Replay Domestic: 877-481-4010
Teleconference Replay International: 919-882-2331
Replay Passcode: 52269

The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.

About BioLargo, Inc.

BioLargo, Inc. (OTCQX: BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.

Contact Information

Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863

SOURCE: BioLargo, Inc

View the original press release on ACCESS Newswire

Ch.Campbell--AT

CMSC	-0.02%	22.865	$
RBGPF	-19.57%	69	$
NGG	2.38%	84.34	$
GSK	3.37%	54.795	$
RYCEF	1.89%	15.9	$
RIO	0.79%	87.46	$
BCE	-0.8%	25.625	$
RELX	-0.25%	32.38	$
CMSD	0.22%	22.68	$
JRI	2.55%	12.17	$
BCC	0.86%	74.21	$
AZN	0.77%	187.22	$
VOD	0.5%	14.734	$
BP	1.61%	45.525	$
BTI	1.08%	58.39	$

Arizona Tribune - BioLargo Year-End 2024 Earnings Results Webcast and Conference Call on Monday, March 31, 2025 - 4:00 PM Eastern Time

BioLargo Year-End 2024 Earnings Results Webcast and Conference Call on Monday, March 31, 2025 - 4:00 PM Eastern Time

Featured

Goat vs gecko: A tiny Caribbean island faces wildlife showdown

Prince Silver Files NI 43-101 Technical Report for Its Stampede Gap Porphyry Copper-Gold-Molybdenum Project in Nevada

Triera Biosciences - a Zentek Company - Launches Contract Research Organization Services for Custom Aptamer Discovery, Biosensor Enablement, and Machine-Learning Classification

Lithium Measurement MR-Technology Provider NanoNord Expands Business with DLE Leader ElectraLith, Following Danish State Visit to Australia